Qutayba Hamid

Active 1985–2025

247
Papers
50,102
Citations
118
h-index
243
i10-index

Citations

Citations per year for Qutayba Hamid1981: 1 citations1987: 2 citations1988: 4 citations1989: 4 citations1990: 2 citations1991: 16 citations1992: 56 citations1993: 110 citations1994: 125 citations1995: 208 citations1996: 197 citations1997: 271 citations1998: 337 citations1999: 428 citations2000: 456 citations2001: 440 citations2002: 347 citations2003: 458 citations2004: 402 citations2005: 413 citations2006: 390 citations2007: 381 citations2008: 398 citations2009: 407 citations2010: 431 citations2011: 468 citations2012: 381 citations2013: 395 citations2014: 329 citations2015: 343 citations2016: 293 citations2017: 345 citations2018: 227 citations2019: 1,024 citations2020: 1,039 citations2021: 1,114 citations2022: 985 citations2023: 608 citations2024: 822 citations2025: 372 citations2026: 1 citations1982–1986: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,113 citing papers, 24% of this breakdownUnited Kingdom: 1,598 citing papers, 9.3% of this breakdownChina: 1,088 citing papers, 6.4% of this breakdownCanada: 846 citing papers, 4.9% of this breakdownItaly: 821 citing papers, 4.8% of this breakdownGermany: 795 citing papers, 4.6% of this breakdownJapan: 700 citing papers, 4.1% of this breakdownAustralia: 594 citing papers, 3.5% of this breakdownFrance: 572 citing papers, 3.3% of this breakdownNetherlands: 510 citing papers, 3% of this breakdownSouth Korea: 386 citing papers, 2.3% of this breakdownSweden: 384 citing papers, 2.2% of this breakdown
0%24%Other 27.6%

Fields

  • Medicine71.9%
  • Immunology and Microbiology12.6%
  • Biochemistry, Genetics and Molecular Biology9%
  • Neuroscience1.4%
  • Environmental Science1.1%
  • Psychology0.7%
  • Other3.3%

Topics

  • Asthma and respiratory diseases17.1%
  • Allergic Rhinitis and Sensitization5.8%
  • IL-33, ST2, and ILC Pathways5.3%
  • Dermatology and Skin Diseases4.1%
  • Respiratory and Cough-Related Research3.5%
  • Chronic Obstructive Pulmonary Disease (COPD) Research2.4%
  • Other61.8%

Coauthors

All papers

Open in search
  1. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

    Authors: , , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2013 cited by 3,924

  2. Histone Modification in NSCLC: Molecular Mechanisms and Therapeutic Targets

    Authors: , , , , - International Journal of Molecular Sciences 2021 cited by 180

  3. New insights into atopic dermatitis

    Authors: , , , , - Journal of Clinical Investigation 2004 cited by 1,407

  4. TH17-associated cytokines (IL-17A and IL-17F) in severe asthma

    Authors: , , , , , , - Journal of Allergy and Clinical Immunology 2009 cited by 625

  5. Role of Transforming Growth Factor–β in Airway Remodeling in Asthma

    Authors: , , , - American Journal of Respiratory Cell and Molecular Biology 2010 cited by 417

  6. GSDMB induces an asthma phenotype characterized by increased airway responsiveness and remodeling without lung inflammation

    Authors: , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 210

  7. Airway Remodelling in Asthma: From Benchside to Clinical Practice

    Authors: , , - Canadian Respiratory Journal 2010 cited by 307

  8. Immunobiology of Asthma

    Authors: , - Annual Review of Physiology 2009 cited by 369

  9. Airway remodeling-associated mediators in moderate to severe asthma: Effect of steroids on TGF-β, IL-11, IL-17, and type I and type III collagen expression

    Authors: , , , , , , , - Journal of Allergy and Clinical Immunology 2003 cited by 640

  10. Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19

    Authors: , , , , - Frontiers in Immunology 2021 cited by 242

  11. Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic Asthma

    Authors: , , , , , , , , - New England Journal of Medicine 1992 cited by 2,766

  12. Long-Term Clinical Efficacy of Grass-Pollen Immunotherapy

    Authors: , , , , , , , , - New England Journal of Medicine 1999 cited by 1,371

  13. Differential Roles of CXCL2 and CXCL3 and Their Receptors in Regulating Normal and Asthmatic Airway Smooth Muscle Cell Migration

    Authors: , , , , , , , , - The Journal of Immunology 2013 cited by 163

  14. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines

    Authors: , , , , , , , , - Journal of Allergy and Clinical Immunology 2001 cited by 949

  15. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients

    Authors: , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2012 cited by 611

  16. Neutrophils are a major source of the epithelial barrier disrupting cytokine oncostatin M in patients with mucosal airways disease

    Authors: , , , , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2016 cited by 150

  17. IL‐5 receptor expression in lung fibroblasts: Potential role in airway remodeling in asthma

    Authors: , , , , , - Allergy 2022 cited by 41

  18. Autophagy: A Versatile Player in the Progression of Colorectal Cancer and Drug Resistance

    Authors: , , , - Frontiers in Oncology 2022 cited by 40

  19. Increased Expression of IL-33 in Severe Asthma: Evidence of Expression by Airway Smooth Muscle Cells

    Authors: , , , , , , , , - The Journal of Immunology 2009 cited by 535

  20. Acidic Mammalian Chitinase in Asthmatic Th2 Inflammation and IL-13 Pathway Activation

    Authors: , , , , , , , - Science 2004 cited by 810

  21. Anti–IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics

    Authors: , , , , , , , - Journal of Allergy and Clinical Immunology 2003 cited by 275

  22. IL-17 Promotes p38 MAPK-Dependent Endothelial Activation Enhancing Neutrophil Recruitment to Sites of Inflammation

    Authors: , , , , , , , , , , - The Journal of Immunology 2010 cited by 269

  23. Upregulation of oxidative stress gene markers during SARS-COV-2 viral infection

    Authors: , , , , , , , - Free Radical Biology and Medicine 2021 cited by 82

  24. Current Status of Baricitinib as a Repurposed Therapy for COVID-19

    Authors: , , , , , , - Pharmaceuticals 2021 cited by 50